维尔生物技术 VIR
$12.21 +$1.19 (+10.80%)
休市 · Nov 8, 5:10 am ET · 最新盘后价 $12.32 +0.91%
开盘$11.30
昨收$11.02
当日区间$11.30 – $12.45
成交量1.90M
市值$2.09B
市盈率（TTM）–
股息率–
财报
财报日平均波动±10.9%近16次财报
收涨次数7 / 1644% 的概率
最佳反应+27.7%
最差反应-14.4%
每次财报后次日股价变动
| 季度 | 财报日期 | 时段 | 隐含波动 | 实际波动 | 较隐含波动 |
|---|---|---|---|---|---|
| 2026/Q2 | 5 Aug 2026 | After Market | ±14.0% | -3.79% | 符合区间 |
| 2026/Q1 | 6 May 2026 | After Market | ±13.5% | -9.91% | 符合区间 |
| 2025/Q4 | 23 Feb 2026 | After Market | ±26.9% | +27.73% | 超出定价预期 |
| 2025/Q3 | 5 Nov 2025 | After Market | ±26.2% | -5.19% | 符合区间 |
| 2025/Q2 | 6 Aug 2025 | After Market | ±11.4% | -14.37% | 超出定价预期 |
| 2025/Q1 | 7 May 2025 | After Market | ±18.7% | -3.57% | 符合区间 |
| 2024/Q4 | 26 Feb 2025 | After Market | ±24.9% | -11.85% | 符合区间 |
| 2024/Q3 | 31 Oct 2024 | After Market | ±14.0% | +23.63% | 超出定价预期 |
| 2024/Q2 | 1 Aug 2024 | After Market | ±15.7% | -5.34% | 符合区间 |
| 2024/Q1 | 2 May 2024 | After Market | ±19.0% | +13.18% | 符合区间 |
| 2023/Q4 | 22 Feb 2024 | After Market | ±21.6% | +11.94% | 符合区间 |
| 2023/Q3 | 2 Nov 2023 | After Market | ±20.7% | +6.96% | 符合区间 |
| 2023/Q2 | 3 Aug 2023 | After Market | ±13.9% | -2.51% | 符合区间 |
| 2022/Q4 | 23 Feb 2023 | After Market | ±15.7% | -10.91% | 符合区间 |
| 2022/Q3 | 3 Nov 2022 | After Market | ±19.0% | +17.71% | 符合区间 |
| 2022/Q2 | 9 Aug 2022 | After Market | ±12.8% | +6.28% | 符合区间 |
"隐含波动"指财报发布前期权市场定价的预期波幅。"波动"指财报发布后首个交易日的股价变化。
基本面
最新报告季度：Q2, ended Jun 2026
营收$238.94M+23,075.1% YoY
营业利润$73.47M+162.0% YoY
净利润$80.08M+172.2% YoY
摊薄每股收益$0.47+158.8% YoY
自由现金流$123.29M+200.4% YoY
经营现金流$123.33M
营收，近8个季度
净利润，近8个季度
盈利能力与资产负债表
毛利率100.0%
营业利润率-92.6%
净利率-83.2%
净资产收益率-26.1%
资产收益率-20.9%
投入资本回报率-25.6%
流动比率6.04
负债/资产比率19.1%
现金及投资$532.73M
总负债$84.14M
净现金（净负债）$448.59M
暂无评论——快来第一个聊聊 VIR。
登录后参与讨论。